Loading…
← CockpitCompetitor Analysis › 603112.SS Shanxi Huaxiang Group Co. Ltd. Class AOpen in the cockpit ↗

Shanxi Huaxiang Group Co. Ltd. Class A603112.SSCompetitor analysis, valuation and peers

China · CNY·Industrials›Miscellaneous Commercial Services

Chinese industrial group; specific business segments not confidently known.

Momentum strong 67
Mkt cap
$1.19B
US dollars, full cap
Free float
37%
of shares outstanding
$/day
$22.9M
20-day average traded
Fwd P/E
11.6×
forward earnings
ROIC−WACC
+4.8 pp
WACC 6.9%
Hurdle
-15 pp
Req g minus delivered
Next earnings
161 days
28 Apr 2027
Close · CNYCN¥14.85
1D-4.6%
1W-11.3%
1M-4.8%
3M-1.4%
6M-33.2%
YTD-14.5%
1Y-13.2%
ATR %5.5%
52w lowhigh38.0% off high

What Shanxi Huaxiang does

Chinese industrial group; specific business segments not confidently known.

Where it sits in the supply chain

  • Industrials

Moat: none

Headquarters: Shanxi, China · Employees: 6,857

Shanxi Huaxiang at a glance

Size Shanxi Huaxiang (603112.SS) is a China Industrials company (Miscellaneous Commercial Services) with a market value of $1.19B, the 1858th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥14.85 on 18 Nov 2026.

Performance Over six months the shares fell 33.2%, against -18.7% for the median peer and -20.0% for the China market (cap-weighted) — 4th lowest of 21 in its peer set.

Growth Revenue grew 9.1% over the last twelve months (peer median +7.9%); the operating margin is 11.2% (peer median 9.6%).

Valuation It trades at 11.6× forward earnings against a peer median of 20.7× (5th cheapest of 17).

Price implies For today's price to make sense, revenue must grow about 1% a year for seven years (Req g). Recent delivered growth is +16%, so the hurdle is -15 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 4.8 points above its cost of capital (6.9% WACC).

Next results Next results expected around 28 Apr 2027 (exchange calendar; dates can move).

Relative performance

608010021 May 202621 Aug 202618 Nov 2026Peer median 82603112.SS 68
Six months, rebased to 100: Shanxi Huaxiang against the median of its 20 peers (local-currency closes).

Shanxi Huaxiang financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥4.39BCN¥4.12BCN¥3.82BCN¥3.25BCN¥3.22B
Revenue growth—+8%+17%+1%—
Gross profitCN¥1.07BCN¥849MCN¥776MCN¥728MCN¥546M
EBITDAn/aCN¥876MCN¥736MCN¥642MCN¥474M
Net incomeCN¥487MCN¥558MCN¥471MCN¥389MCN¥264M
Free cash flowCN¥84.4M-CN¥69.6MCN¥342MCN¥202M-CN¥158M
Capital expenditureCN¥89.4MCN¥141MCN¥140MCN¥114MCN¥321M
Total debtCN¥2.14BCN¥928MCN¥1.78BCN¥1.51BCN¥1.58B

Quarterly statements and history in the cockpit →

Shanxi Huaxiang competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%+20%+40%-20%0%6881121515RHLD688252WLDNCONCORDBIO68813768880060064506676883519746CASH688392002338600654688128BMAG2384603112.SS6-month return →1-month return →
Up and to the right = strong over both horizons. Shanxi Huaxiang is the large dot.

Fundamentals: revenue growth against valuation

-50%-25%0%+25%0×50×100×688112688252WLDNCONCORDBIO6006456008610667688351CASH688392002338BMAG603112.SSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Shanxi Huaxiang is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%+60%0%20%40%60%688112688252WLDNCONCORDBIO68880060064506676883519746CASH6006546881282384603112.SSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Shanxi Huaxiang is the large dot.

Shanxi Huaxiang competitors and peer comparison

How Shanxi Huaxiang compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Shanxi Huaxiang against its 20 peers (data as of 18 Nov 2026)
Measure603112.SSPeer medianRank in peer set
1-month return-4.8%-6.2%11th highest of 21
6-month return-33.2%-18.7%4th lowest of 21
Distance from 52-week high-38.0%-37.5%10th lowest of 21
Revenue growth (TTM)+9.1%+7.9%10th highest of 21
Operating margin11.2%9.6%9th highest of 21
Forward P/E11.6×20.7×5th cheapest of 17
Growth the price implies (Req g, 7 yrs)0.9%14.3%5th least demanding of 15
Growth delivered (Del g)+16.2%+11.8%5th highest of 14
Hurdle (Req g minus delivered)-15.3 pp-10.4 pp6th least demanding of 14
ROIC minus cost of capital+4.8 pp-0.2 pp8th highest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Shanxi Huaxiang 603112.SSChina$1.19B-33%+9%11%11.6×0.9%+16.2%
Siglent Technologies 688112.SSChina$1.19B-26%+30%24%39.2×27.7%+22.0%
Nittetsu Mining 1515.TJapan$1.17B-3%+18%8%n/an/an/a
Resolute Holdings Management RHLDUnited States$1.16B+34%+10%12%n/a16.6%n/a
Jadard Technology 688252.SSChina$1.14B-22%+6%12%22.3×12.0%+31.3%
Willdan WLDNUnited States$1.13B-20%+19%7%14.6×17.2%+11.8%
Concord Biotech CONCORDBIO.NSIndia$1.26B-2%+4%28%33.9×44.4%+11.6%
Suzhou Novoprotein Scientific 688137.SSChina$1.12B+117%+8%-62%n/an/an/a
Suzhou Recodeal Interconnect System 688800.SSChina$1.26B-68%+5%9%31.0×22.7%+38.9%
Vcanbio Cell & Gene Engineering 600645.SSChina$1.11B-29%-6%12%40.7×8.9%+1.9%
FESCO 600861.SSChina$1.10B-15%+4%1%10.5×n/an/a
China East Education 0667.HKHong Kong$1.09B-21%+16%22%7.8×-7.5%+4.1%
Shanghai MicroPort EP Medtech 688351.SSChina$1.31B-30%+20%3%137.1×42.5%+26.7%
TKC 9746.TJapan$1.31B+22%+5%20%19.1×-10.1%+5.7%
Prosegur Cash CASH.MCSpain$1.07B+10%-2%11%9.6×-12.1%+5.7%
SBT Ultrasonic Technology 688392.SSChina$1.06B-36%+42%17%49.3×n/an/a
Changchun Up Optotech 002338.SZChina$1.34B-41%+22%2%43.1×n/an/a
China Security 600654.SSChina$1.34B-31%-30%-1%n/a56.0%+0.4%
China National Electric Apparatus Research Institute 688128.SSChina$1.35B-17%+8%11%14.7×3.2%+13.5%
Bajaj Mobility BMAG.SWSwitzerland$1.05B+40%-47%-44%8.9×n/an/a
SBS 2384.TJapan$1.35B+26%+17%5%13.9×-4.7%+13.8%

Questions

Which companies are Shanxi Huaxiang's closest peers?
The cockpit's peer set: Siglent Technologies (688112.SS), Nittetsu Mining (1515.T), Resolute Holdings Management (RHLD), Jadard Technology (688252.SS), Willdan (WLDN), Concord Biotech (CONCORDBIO.NS), Suzhou Novoprotein Scientific (688137.SS), Suzhou Recodeal Interconnect System (688800.SS).
Is Shanxi Huaxiang expensive compared with its peers?
On forward p/e it trades at 11.6× against a peer median of 20.7×, 5th cheapest of 17 in its peer set. For today's price to make sense, revenue must grow about 1% a year for seven years (Req g). Recent delivered growth is +16%, so the hurdle is -15 pp: the price already allows for a slowdown.
How has Shanxi Huaxiang stock performed?
Over six months to 18 Nov 2026 the shares returned -33.2% against -18.7% for the median peer; over one year -13.2%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.